https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-04-01 / Melanoma Res. 2019 04;29(2):109-118
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-04-01 / Melanoma Res. 2019 04;29(2):109-1182019-04-01 00:00:002019-04-01 00:00:00Melanoma vaccines: clinical status and immune endpoints
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2018-06-04 / Clin Transl Oncol 2018 Dec;20(12):1502-1521
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2018-06-04 / Clin Transl Oncol 2018 Dec;20(12):1502-15212019-03-27 11:14:362019-03-27 11:14:36New physical approaches to treat cancer stem cells: a review
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-03-03 / Br. J. Haematol. 2019 Mar;
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-03-03 / Br. J. Haematol. 2019 Mar;2019-03-03 00:00:002019-03-03 00:00:00Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-857
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-8572019-02-19 00:00:002019-02-19 00:00:00Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
https://www.iozk.de/wp-content/uploads/2019/03/Einladung-Symposium.jpg
999
2000
IOZK
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
IOZK2019-02-12 19:14:282019-03-25 17:17:08Symposium & Fortbildung am IOZK: Immuntherapie in der Neuroonkologie, Fr. 06.09.2019
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-12 / Br J Radiol 2019 Mar;92(1095):20180759
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-12 / Br J Radiol 2019 Mar;92(1095):201807592019-02-12 00:00:002019-02-12 00:00:00Mild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-06 / Front Oncol 2019;9:50
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-06 / Front Oncol 2019;9:502019-02-06 00:00:002019-02-06 00:00:00On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-02-01 / Immunotherapy 2019 Feb;11(2):75-79
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-02-01 / Immunotherapy 2019 Feb;11(2):75-792019-02-01 00:00:002019-02-01 00:00:00The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-12 / Life Sci. 2019 Feb;219:136-143
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-12 / Life Sci. 2019 Feb;219:136-1432019-01-12 00:00:002019-01-12 00:00:00Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
0
0
2019-01-01 / Methods Mol. Biol. 2019;1884:317-333
https://www.iozk.de/wp-content/uploads/2019/03/Logo-header560x120.svg
2019-01-01 / Methods Mol. Biol. 2019;1884:317-3332019-01-01 00:00:002019-01-01 00:00:00A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
Melanoma vaccines: clinical status and immune endpoints
/in Dendritic Cells, Malignant Melanoma, Publikationen /von 2019-04-01 / Melanoma Res. 2019 04;29(2):109-118New physical approaches to treat cancer stem cells: a review
/in Hyperthermia, Publikationen /von 2018-06-04 / Clin Transl Oncol 2018 Dec;20(12):1502-1521Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine
/in Acute Leukemia, Dendritic Cells, Publikationen /von 2019-03-03 / Br. J. Haematol. 2019 Mar;Maintenance of long remission in adult T-cell leukemia by Tax-targeted vaccine: A hope for disease-preventive therapy
/in Acute Leukemia, Dendritic Cells, Publikationen /von 2019-02-19 / Cancer Sci. 2019 Mar;110(3):849-857Symposium & Fortbildung am IOZK: Immuntherapie in der Neuroonkologie, Fr. 06.09.2019
/in IOZK bei Fachtagungen, IOZK Meldungen /von IOZKMild hyperthermia as a localized radiosensitizer for deep-seated tumors: investigation in an orthotopic prostate cancer model in mice
/in Hyperthermia, Publikationen /von 2019-02-12 / Br J Radiol 2019 Mar;92(1095):20180759On the Other Side: Manipulating the Immune Checkpoint Landscape of Dendritic Cells to Enhance Cancer Immunotherapy
/in Checkpoint-Inhibitors, Dendritic Cells, Publikationen /von 2019-02-06 / Front Oncol 2019;9:50The evolving clinical landscape for dendritic cell vaccines and cancer immunotherapy
/in Dendritic Cells, Publikationen /von 2019-02-01 / Immunotherapy 2019 Feb;11(2):75-79Induction of T cell-mediated immune response by dendritic cells pulsed with mRNA of sphere-forming cells isolated from patients with gastric cancer
/in Dendritic Cells, Gastric Cancer, Publikationen /von 2019-01-12 / Life Sci. 2019 Feb;219:136-143A Novel Dendritic Cell-Based Vaccination Protocol to Stimulate Immunosurveillance of Aggressive Cancers
/in Dendritic Cells, Publikationen /von 2019-01-01 / Methods Mol. Biol. 2019;1884:317-333